Preliminary results of the European Multicenter Study on UW solution in liver transplantation. The Study Group.
The introduction of UW solution in clinical liver transplantation has had a tremendous impact on clinical practice. The preliminary evaluation of data in this interim report with UW solution in the European setting does confirm the clinical results as reported by the Belzer and Starzl groups. These data on the UW solution in its original composition concern in already 43% a population of liver transplant procedures performed with cold ischemia times of more than 12 hours without clinical evidence of detrimental effects due to preservation times up to 26 hours. A comprehensive analysis of the results of this study will be performed upon completion of the 1 and 3 month follow-up. In this analysis all preservation related characteristics will be presented and statistically evaluated.
Ploeg
R J
RJ
Department of Surgery, University of Leiden, The Netherlands.
D000241:Adenosine; D000493:Allopurinol; D005060:Europe; D005978:Glutathione; D006801:Humans; D007328:Insulin; D016031:Liver Transplantation / Q000379:methods / Q000502:physiology*; D009926:Organ Preservation / Q000379:methods*; D019188:Organ Preservation Solutions; D011887:Raffinose; D012996:Solutions
D007328:Insulin; D019188:Organ Preservation Solutions; D012996:Solutions; C055206:University of Wisconsin-lactobionate solution; D000493:Allopurinol; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose